Venture Capital

An Innventure company proves its technology can turn real-world plastic trash into valuable chemicals, but can it navigate the path to commercialization?

With a new Dubai office and MD, Asia Bankers Club aims to bridge global capital flows, leveraging the city's rise as an investment command center.

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Palo Alto Networks acquires Koi for a reported $400M, aiming to secure the new 'Agentic Endpoint' and define the next era of enterprise AI security.

The toy giant unveils its 2026 lineup, blending high-tech pets with purposeful play and making a bold, strategic move into the lucrative adult gaming market.

With an $8M Series A, QuadSci's AI analyzes user behavior to predict churn up to 18 months out, promising to fix the SaaS industry's revenue problem.

North American Niobium unveils high-grade niobium and rare earth assays at its Seigneurie Project, positioning Québec as a key hub for strategic minerals.

A new series from A3 and BBC StoryWorks moves beyond efficiency to show how automation is augmenting human lives in healthcare, education, and more.

SaaS veteran Alison Forsythe takes the helm at Intellinetics, tasked with turning heavy investment into profitable growth in the booming digital transformation market.

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.

A new partnership aims to manufacture a life-saving gene therapy for NKH, a devastating rare disorder, driven by a family's relentless advocacy.

Boundless Futures Foundation and Ladies Who Launch partner to provide funding and vital resources, creating a new ecosystem for mission-driven female founders.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

Ceva's AI licensing revenue soared in 2025, securing deals with a top PC OEM and Microchip, signaling a major industry shift to on-device intelligence.

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.

Shutterstock posts record 2025 revenue on AI data growth, but a steep Q4 loss and merger costs reveal deep challenges in its core content business.

Ascend Elements' award to TDK Ventures reveals a new VC model, where hands-on partnership is key to building a secure, circular battery supply chain.

Tech giant Sony secures access to crucial 5G, Wi-Fi, and video patents, renewing a long-standing agreement with R&D powerhouse InterDigital.

Fortrea splits key roles, dedicating its CMO to scientific strategy and hiring a new president for clinical pharmacology in a bold post-spin-off move.